Xiao-Jun Lin (Xiaojun Lin)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 15

Top Topics

Locally Advanced

Cancer Stem Cells

Liver Metastases

Radiofrequency Ablation

Top Venues

Journal of translational medicine

Journal of inflammation research

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Guizhong Huang, Pu Xi, Zehui Yao, Chongyu Zhao, Xiaohui Li, Zexian Chen, Xiao-Jun Lin
The Clinical Association Between the Inflammation-Nutritional Condition and Prognosis of Locally Advanced Intrahepatic Cholangiocarcinoma After R0 Resection: Evidence from Competing Risk and Propensity Matching Analysis. Journal of inflammation research 17 (2024)
Guizhong Huang, Pu Xi, Zehui Yao, Chongyu Zhao, Xiaohui Li, Zexian Chen, Xiao-Jun Lin
The Clinical Association Between the Inflammation-Nutritional Condition and Prognosis of Locally Advanced Intrahepatic Cholangiocarcinoma After R0 Resection: Evidence from Competing Risk and Propensity Matching Analysis. Journal of inflammation research 17 (2024)
Xiao-Hui Li, En-Liang Zhou, Chong-Yu Zhao, Bo-Kang Cui, Xiao-Yuan Dong, Hang Du, Xiao-Jun Lin
Adjuvant chemotherapy combined with immunotherapy in patients with cholangiocarcinoma after radical resection. Cancer medicine (2023)
Xiao-Hui Li, Gui-Zhong Huang, Zi-Lan Xu, Chong-Yu Zhao, Xiao-Yuan Dong, Bo-Kang Cui, Xiao-Jun Lin
IL20RB signaling enhances stemness and chemotherapy resistance in pancreatic cancer. Journal of translational medicine 21 (1) (2023)
Xiao-Hui Li, Gui-Zhong Huang, Zi-Lan Xu, Chong-Yu Zhao, Xiao-Yuan Dong, Bo-Kang Cui, Xiao-Jun Lin
IL20RB signaling enhances stemness and chemotherapy resistance in pancreatic cancer. Journal of translational medicine 21 (1) (2023)
Xiao-Hui Li, Gui-Zhong Huang, Zi-Lan Xu, Chong-Yu Zhao, Xiao-Yuan Dong, Bo-Kang Cui, Xiao-Jun Lin
IL20RB signaling enhances stemness and chemotherapy resistance in pancreatic cancer. Journal of translational medicine 21 (1) (2023)
Xiao-Hui Li, Gui-Zhong Huang, Zi-Lan Xu, Chong-Yu Zhao, Xiao-Yuan Dong, Bo-Kang Cui, Xiao-Jun Lin
IL20RB signaling enhances stemness and chemotherapy resistance in pancreatic cancer. Journal of translational medicine 21 (1) (2023)
Xiao-Hui Li, Gui-Zhong Huang, Zi-Lan Xu, Chong-Yu Zhao, Xiao-Yuan Dong, Bo-Kang Cui, Xiao-Jun Lin
IL20RB signaling enhances stemness and chemotherapy resistance in pancreatic cancer. Journal of translational medicine 21 (1) (2023)
Chaobin He, Chongyu Zhao, Yu Zhang, Cheng Chen, Xiao-Jun Lin
An Inflammation-Index Signature Predicts Prognosis of Patients with Intrahepatic Cholangiocarcinoma After Curative Resection. Journal of inflammation research 14 (2021)
Chaobin He, Zhiyuan Cai, Yu Zhang, Xiao-Jun Lin
Comparative Recurrence Analysis of Pancreatic Adenocarcinoma after Resection. Journal of oncology 2021 (2021)
Chaobin He, Jun Wang, Yu Zhang, Zhiyuan Cai, Xiao-Jun Lin, Shengping Li
Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation. Cancer medicine 9 (13) (2020)
Chaobin He, Yu Zhang, Zhiyuan Cai, Xiao-Jun Lin
Competing risk analyses of overall survival and cancer-specific survival in patients with combined hepatocellular cholangiocarcinoma after surgery. BMC cancer 19 (1) (2019)
Chaobin He, Yu Zhang, Zhiyuan Cai, Xiao-Jun Lin
Effect of prior cancer on survival outcomes for patients with pancreatic adenocarcinoma: a propensity score analysis. BMC cancer 19 (1) (2019)
Chaobin He, Yu Zhang, Xiao-Jun Lin
Increased Overall Survival and Decreased Cancer-Specific Mortality in Patients with Hepatocellular Carcinoma Treated by Transarterial Chemoembolization and Human Adenovirus Type-5 Combination Therapy: a Competing Risk Analysis. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 22 (6) (2018)
Chao-Bin He, Xiao-Jun Lin
Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101. PloS one 12 (3) (2017)